Salarius Pharmaceuticals Inc (SLRX)
0.5074
+0.02
(+4.15%)
USD |
NASDAQ |
May 09, 16:00
0.4728
-0.03
(-6.82%)
Pre-Market: 20:00
Salarius Pharmaceuticals Price to Book Value: 0.414 for May 9, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 0.414 |
| May 08, 2024 | 0.3976 |
| May 07, 2024 | 0.3884 |
| May 06, 2024 | 0.3925 |
| May 03, 2024 | 0.4088 |
| May 02, 2024 | 0.4305 |
| May 01, 2024 | 0.4376 |
| April 30, 2024 | 0.4072 |
| April 29, 2024 | 0.3949 |
| April 26, 2024 | 0.404 |
| April 25, 2024 | 0.4072 |
| April 24, 2024 | 0.4145 |
| April 23, 2024 | 0.4088 |
| April 22, 2024 | 0.4176 |
| April 19, 2024 | 0.4024 |
| April 18, 2024 | 0.3956 |
| April 17, 2024 | 0.4166 |
| April 16, 2024 | 0.408 |
| April 15, 2024 | 0.4051 |
| April 12, 2024 | 0.408 |
| April 11, 2024 | 0.3998 |
| April 10, 2024 | 0.3845 |
| April 09, 2024 | 0.3917 |
| April 08, 2024 | 0.386 |
| April 05, 2024 | 0.3998 |
| Date | Value |
|---|---|
| April 04, 2024 | 0.4141 |
| April 03, 2024 | 0.3975 |
| April 02, 2024 | 0.369 |
| April 01, 2024 | 0.4031 |
| March 28, 2024 | 0.4313 |
| March 27, 2024 | 0.3958 |
| March 26, 2024 | 0.3998 |
| March 25, 2024 | 0.4162 |
| March 22, 2024 | 0.5059 |
| March 21, 2024 | 0.4774 |
| March 20, 2024 | 0.4897 |
| March 19, 2024 | 0.5374 |
| March 18, 2024 | 0.4929 |
| March 15, 2024 | 0.5304 |
| March 14, 2024 | 0.5186 |
| March 13, 2024 | 0.5059 |
| March 12, 2024 | 0.5213 |
| March 11, 2024 | 0.4923 |
| March 08, 2024 | 0.5061 |
| March 07, 2024 | 0.4991 |
| March 06, 2024 | 0.5065 |
| March 05, 2024 | 0.5065 |
| March 04, 2024 | 0.4842 |
| March 01, 2024 | 0.4909 |
| February 29, 2024 | 0.4991 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.155
Minimum
Dec 28 2022
9.318
Maximum
Jul 19 2019
0.9967
Average
0.7462
Median
Apr 27 2023
Price to Book Value Benchmarks
| Masimo Corp | 4.826 |
| Esperion Therapeutics Inc | -- |
| SINTX Technologies Inc | 0.6112 |
| Flora Growth Corp | 2.369 |
| NovaBay Pharmaceuticals Inc | 1.970 |
Price to Book Value Related Metrics
| Price | 0.5074 |
| Earnings Yield | -849.4% |
| Market Cap | 2.189M |